Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs

Public involvement successful obesity medicine has risen 25-fold since the motorboat of GLP-1 receptor agonist drugs, caller probe presented astatine the International Congress connected Obesity (ICO2026) successful Mexico City, Mexico, hosted by the World Obesity Federation (July 15–17) shows.